Better Therapeutics Inc
OTC:BTTX
Cash Flow Statement
Cash Flow Statement
Better Therapeutics Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(40)
|
(50)
|
(60)
|
(71)
|
(40)
|
(39)
|
(37)
|
(32)
|
|
| Depreciation & Amortization |
2
|
2
|
3
|
4
|
3
|
3
|
3
|
3
|
|
| Change in Deffered Taxes |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
10
|
11
|
11
|
12
|
2
|
2
|
2
|
2
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
(2)
|
(3)
|
(0)
|
2
|
6
|
6
|
5
|
1
|
|
| Cash from Operating Activities |
(31)
N/A
|
(39)
-28%
|
(46)
-17%
|
(53)
-15%
|
(29)
+45%
|
(29)
+0%
|
(27)
+6%
|
(26)
+4%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
|
| Cash from Investing Activities |
(1)
N/A
|
56
N/A
|
56
-1%
|
56
-1%
|
(1)
N/A
|
(2)
-41%
|
(2)
-5%
|
(1)
+24%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
0
|
(58)
|
(58)
|
(58)
|
0
|
0
|
7
|
13
|
|
| Net Issuance of Debt |
10
|
0
|
15
|
15
|
5
|
5
|
(1)
|
(1)
|
|
| Other |
62
|
63
|
63
|
63
|
0
|
0
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
72
N/A
|
14
-80%
|
19
+36%
|
19
N/A
|
5
-73%
|
5
-8%
|
5
+12%
|
12
+116%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
40
N/A
|
31
-23%
|
29
-6%
|
22
-25%
|
(25)
N/A
|
(26)
-3%
|
(23)
+8%
|
(16)
+33%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(32)
N/A
|
(41)
-27%
|
(48)
-17%
|
(55)
-15%
|
(30)
+45%
|
(30)
-1%
|
(29)
+5%
|
(27)
+5%
|
|